107 related articles for article (PubMed ID: 27458253)
41. [Cervix dysplasias: study of Rb and p53 gene expression and correlation with mitotic activity].
Mathevet P; Frappart L; Hittelman W
Gynecol Obstet Fertil; 2000 Jan; 28(1):44-50. PubMed ID: 10774117
[TBL] [Abstract][Full Text] [Related]
42. Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance.
Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2008 Oct; 99(10):1984-91. PubMed ID: 19016758
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
Moshi JM; Ummelen M; Smedts F; Ramaekers FCS; Hopman AHN
PLoS One; 2024; 19(4):e0297008. PubMed ID: 38635731
[TBL] [Abstract][Full Text] [Related]
44. Exploring the p53 connection of cervical cancer pathogenesis involving north-east Indian patients.
Khan MA; Tiwari D; Dongre A; Sadaf ; Mustafa S; Das CR; Massey S; Bose PD; Bose S; Husain SA
PLoS One; 2020; 15(9):e0238500. PubMed ID: 32976537
[TBL] [Abstract][Full Text] [Related]
45. Alterations of the P16 gene in uterine cervical carcinoma from Indian patients.
Tripathi A; Banerjee S; Roy A; Roychowdhury S; Panda CK
Int J Gynecol Cancer; 2003; 13(4):472-9. PubMed ID: 12911724
[TBL] [Abstract][Full Text] [Related]
46. Claudin 1 expression characterizes human uterine cervical reserve cells.
Zinner B; Gyöngyösi B; Babarczi E; Kiss A; Sobel G
J Histochem Cytochem; 2013 Dec; 61(12):880-8. PubMed ID: 23900598
[TBL] [Abstract][Full Text] [Related]
47. Deregulation of H19 is associated with cervical carcinoma.
Roychowdhury A; Samadder S; Das P; Mazumder DI; Chatterjee A; Addya S; Mondal R; Roy A; Roychoudhury S; Panda CK
Genomics; 2020 Jan; 112(1):961-970. PubMed ID: 31229557
[TBL] [Abstract][Full Text] [Related]
48. Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 in cervical intraepithelial neoplasia.
Li RN; Li CY; Lee CH; Peng CY; Wu MT
Oncol Lett; 2017 Jun; 13(6):4397-4401. PubMed ID: 28599442
[TBL] [Abstract][Full Text] [Related]
49. Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells.
Zhao Y; Lai Y; Ge H; Guo Y; Feng X; Song J; Wang Q; Fan L; Peng Y; Cao M; Harris AL; Wang X; Tao L
Cell Death Dis; 2017 May; 8(5):e2773. PubMed ID: 28492539
[TBL] [Abstract][Full Text] [Related]
50. Value of AgNOR counts in cervical pathology.
Leopardi O; Colavecchio M; Colecchia M; Dedè A
Eur J Gynaecol Oncol; 1992; 13(6):539-44. PubMed ID: 1473536
[TBL] [Abstract][Full Text] [Related]
51. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.
Kashuba VI; Li J; Wang F; Senchenko VN; Protopopov A; Malyukova A; Kutsenko AS; Kadyrova E; Zabarovska VI; Muravenko OV; Zelenin AV; Kisselev LL; Kuzmin I; Minna JD; Winberg G; Ernberg I; Braga E; Lerman MI; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4906-11. PubMed ID: 15051889
[TBL] [Abstract][Full Text] [Related]
52. Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus.
Pfeiffer D; Kimmig R; Herrmann J; Ruge M; Fisseler-Eckhoff A; Scheidel P; Jensen A; Schatz H; Pfeiffer A
Int J Cancer; 1998 Feb; 79(1):49-55. PubMed ID: 9495358
[TBL] [Abstract][Full Text] [Related]
53. Identification of HPV16 positive cervical cancer subsets characterized by divergent immune and oncogenic phenotypes with potential implications for immunotherapy.
Ghosh A; Ghosh A; Sinha A; Mathai S; Bhaumik J; Mukhopadhyay A; Maitra A; Biswas NK; Majumder PP; Sengupta S
Tumour Biol; 2023; 45(1):55-69. PubMed ID: 37599552
[TBL] [Abstract][Full Text] [Related]
54. Ionizing Radiation Combined with PARP1 Inhibitor Reduces Radioresistance in Prostate Cancer with RB1/TP53 Loss.
Fan Y; Fan H; Quan Z; Wu X
Cancer Invest; 2021 May; 39(5):423-434. PubMed ID: 33683975
[TBL] [Abstract][Full Text] [Related]
55. Kinetics of cell replication of the uterine cervix. II. Parabasal cell production in atypical epithelium.
Beyer-Boon ME; Rubio CA
Oncology; 1980; 37(1):27-9. PubMed ID: 7350551
[TBL] [Abstract][Full Text] [Related]
56. Detection of Aberrant DNA Methylation Patterns in the RB1 Gene.
Anwar SL; Lehmann U
Methods Mol Biol; 2018; 1726():35-47. PubMed ID: 29468542
[TBL] [Abstract][Full Text] [Related]
57. Cervical cancer subtypes harbouring integrated and/or episomal HPV16 portray distinct molecular phenotypes based on transcriptome profiling of mRNAs and miRNAs.
Mandal P; Saha SS; Sen S; Bhattacharya A; Bhattacharya NP; Bucha S; Sinha M; Chowdhury RR; Mondal NR; Chakravarty B; Chatterjee T; Roy S; Chattapadhyay A; Sengupta S
Cell Death Discov; 2019; 5():81. PubMed ID: 30937183
[TBL] [Abstract][Full Text] [Related]
58. Differential expression of DNA repair genes and treatment outcome of chemoradiotherapy (CRT) in cervical cancer.
Kushwah AS; Srivastava K; Banerjee M
Gene; 2023 Jun; 868():147389. PubMed ID: 36963733
[TBL] [Abstract][Full Text] [Related]
59. The
Berry JL; Polski A; Cavenee WK; Dryja TP; Murphree AL; Gallie BL
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31683923
[TBL] [Abstract][Full Text] [Related]
60. High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.
Kashuba VI; Pavlova TV; Grigorieva EV; Kutsenko A; Yenamandra SP; Li J; Wang F; Protopopov AI; Zabarovska VI; Senchenko V; Haraldson K; Eshchenko T; Kobliakova J; Vorontsova O; Kuzmin I; Braga E; Blinov VM; Kisselev LL; Zeng YX; Ernberg I; Lerman MI; Klein G; Zabarovsky ER
PLoS One; 2009 May; 4(5):e5231. PubMed ID: 19478941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]